WO2017064558A8 - 新規免疫賦活化剤 - Google Patents
新規免疫賦活化剤 Download PDFInfo
- Publication number
- WO2017064558A8 WO2017064558A8 PCT/IB2016/001543 IB2016001543W WO2017064558A8 WO 2017064558 A8 WO2017064558 A8 WO 2017064558A8 IB 2016001543 W IB2016001543 W IB 2016001543W WO 2017064558 A8 WO2017064558 A8 WO 2017064558A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- immunostimulant
- novel
- novel immunostimulant
- tetrahydropyrimido
- indolizin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
この発明は、下記の式(I)で表される(S)-N(4-アミノ-5-(キノリン-3-イル)-6,7,8,9-テトラヒドロピリミド[5,4-b]インドリジン-8-イル)アクリルアミドまたはその塩を有効成分として含有する免疫賦活化剤、および免疫賦活化により改善することができる疾患を予防または治療するための医薬組成物に関する。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015-203282 | 2015-10-14 | ||
JP2015203282 | 2015-10-14 | ||
JP2016-148854 | 2016-07-28 | ||
JP2016148854A JP2017075137A (ja) | 2015-10-14 | 2016-07-28 | 新規免疫賦活化剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2017064558A1 WO2017064558A1 (ja) | 2017-04-20 |
WO2017064558A8 true WO2017064558A8 (ja) | 2017-08-17 |
Family
ID=58517074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2016/001543 WO2017064558A1 (ja) | 2015-10-14 | 2016-10-28 | 新規免疫賦活化剤 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017064558A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108101905A (zh) * | 2016-11-24 | 2018-06-01 | 中国科学院上海药物研究所 | 嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途 |
CN115607573B (zh) * | 2022-12-16 | 2023-05-23 | 北京大学第三医院(北京大学第三临床医学院) | 一种用于调节杀伤性t细胞活性的方法、药物及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012512883A (ja) * | 2008-12-19 | 2012-06-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ウイルス感染の治療における上皮成長因子阻害剤の使用 |
ES2580530T3 (es) * | 2012-02-23 | 2016-08-24 | Taiho Pharmaceutical Co., Ltd. | Compuesto con anillo fusionado de quinolilpirrolopirimidilo o sal del mismo |
US20150079079A1 (en) * | 2013-09-13 | 2015-03-19 | Wake Forest University Health Sciences | Methods and Compositions for Treatment of Chlamydial Infection and Related Diseases and Disorders |
-
2016
- 2016-10-28 WO PCT/IB2016/001543 patent/WO2017064558A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017064558A1 (ja) | 2017-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017100726A8 (en) | Methods for treating huntington's disease | |
EP3481402A4 (en) | CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING A DISEASE | |
WO2017070616A3 (en) | Sexually transmitted disease vaccines | |
PH12016501898B1 (en) | Quinoxaline derivatives useful as fgfr kinase modulators | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
WO2016105525A3 (en) | Novel pyrimidines as egfr inhibitors and methods of treating disorders | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
WO2016011306A3 (en) | Terminal modifications of polynucleotides | |
WO2016130920A3 (en) | Lrrk2 inhibitors and methods of making and using the same | |
WO2015001504A3 (en) | Antibody formulations and methods | |
MX2015012414A (es) | Sal de omecamtiv mecarbilo y proceso para preparar la sal. | |
PH12016500814B1 (en) | Heteroaryl butanoic acid derivatives | |
WO2015104658A3 (en) | Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin | |
WO2015191945A3 (en) | Solid state forms of sofosbuvir | |
EP3034082A4 (en) | Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients | |
CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
EP3231436A4 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
WO2016011049A3 (en) | Compositions and methods for disease treatment using nanoparticle delivered compounds | |
EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
PH12016502568B1 (en) | Novel heterocyclic compound | |
EP3311817A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF EYES DISEASES WITH IMATINIB AS AN ACTIVE SUBSTANCE | |
WO2016063289A3 (en) | Pharmaceutical tablet compositions comprising rifaximin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16855012 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16855012 Country of ref document: EP Kind code of ref document: A1 |